What does UTMD's latest earnings reveal about its financial health?

Utah Medical Products (UTMD) reported a net income of $2.9 million and total revenue of $9.16 million for the fiscal quarter ending December 31, 2024. The company's financial health appears to be stable, with a positive net income indicating profitability and a reasonable revenue figure suggesting a healthy business operation. However, the lack of information on the diluted EPS makes it difficult to fully assess the company's earnings quality and potential returns for investors.

|code|Ticker|Name|Date|Total Revenue|Net Income|Diluted EPS|market_code|
|---|---|---|---|---|---|---|---|
|UTMD|UTMD.O|Utah Medical Products|2024 Q1|1.134E7|3956000|1.09|185|
|UTMD|UTMD.O|Utah Medical Products|2024 Q2|1.04E7|3453000|0.98|185|
|UTMD|UTMD.O|Utah Medical Products|2024 Q3|1.0005E7|3563000|1.02|185|
|UTMD|UTMD.O|Utah Medical Products|2024 Q4|9158000|2902000||185|